[i] Furthermore, [we] demonstrated that an MHC like molecule, called CD1d, loaded with a glycolipid ligand, called alphaGalCer, also targeted to the tumor cells by monoclonal antibodies, was capable to
specifically inhibit tumor growth in vivo and to give a sustained activation of the Natural Killer Cells known to be important in the
innate immunity.